Literature DB >> 15241685

Clinical and biochemical manifestations of syndrome X in obese children.

Efimia Papadopoulou-Alataki1, Kiriaki Papadopoulou-Legbelou, Loukas Doukas, Kiparissia Karatzidou, Aikaterini Pavlitou-Tsiontsi, Emmanouil Pagkalos.   

Abstract

UNLABELLED: The aim of this study was to investigate whether the clinical and metabolic characteristics of syndrome X had their onset in childhood in otherwise healthy but obese children of Greek origin. A group of 25 obese children and 18 age- and sex matched control subjects, aged 6-14 years, underwent an oral glucose tolerance test (OGTT), assessed for determination of plasma glucose and insulin levels. Insulin sensitivity and insulin resistance were estimated by mathematical models using calculations obtained during the OGTT. Body mass index (BMI) and blood pressure were measured, as well as serum lipoprotein and aminotransferase concentrations, after an overnight fast. The obese children had significantly higher blood pressure (systolic and diastolic) (P<0.001), triglycerides, lipoprotein(a) and alanine aminotransferase levels (P<0.05) and significantly lower HDL-cholesterol and apolipoprotein A-1 values (P<0.001). Plasma glucose levels during the OGTT were similar in both obese children and control subjects, while plasma insulin levels were significantly higher in obese children (P<0.01). In mathematical models, mean values of insulin sensitivity predictors: metabolic clearance rate and insulin sensitivity index were significantly lower in obese children (P<0.001). Predictors of beta-cell function: insulin resistance index and insulin release index were significantly higher in obese children (P<0.001).
CONCLUSION: Childhood adiposity was associated with all traditional components of syndrome X. The early recognition of these factors as predisposing elements of the appearance of metabolic syndrome requires the development of strategies to manage excess weight gain during childhood, with the ultimate goal being the prevention of type 2 diabetes and cardiovascular disease in adulthood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241685     DOI: 10.1007/s00431-004-1483-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  31 in total

1.  Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

Authors:  M Stumvoll; A Mitrakou; W Pimenta; T Jenssen; H Yki-Järvinen; T Van Haeften; W Renn; J Gerich
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

Review 2.  Overweight children and adolescents: description, epidemiology, and demographics.

Authors:  R P Troiano; K M Flegal
Journal:  Pediatrics       Date:  1998-03       Impact factor: 7.124

3.  Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.

Authors:  J B Meigs; R B D'Agostino; P W Wilson; L A Cupples; D M Nathan; D E Singer
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

4.  Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present?

Authors:  S Arslanian; C Suprasongsin
Journal:  J Clin Endocrinol Metab       Date:  1996-03       Impact factor: 5.958

5.  Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children.

Authors:  D Young-Hyman; D G Schlundt; L Herman; F De Luca; D Counts
Journal:  Diabetes Care       Date:  2001-08       Impact factor: 19.112

Review 6.  Molecular physiology and genetics of NIDDM. Importance of metabolic staging.

Authors:  D K Granner; R M O'Brien
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

7.  Relation of fasting insulin to blood pressure and lipids in adolescents and parents.

Authors:  A R Sinaiko; O Gomez-Marin; R J Prineas
Journal:  Hypertension       Date:  1997-12       Impact factor: 10.190

8.  Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.

Authors:  D Dabelea; D J Pettitt; R L Hanson; G Imperatore; P H Bennett; W C Knowler
Journal:  Diabetes Care       Date:  1999-06       Impact factor: 19.112

9.  Effects of doxazosin, a selective alpha 1-inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension.

Authors:  C Giorda; M Appendino
Journal:  Metabolism       Date:  1993-11       Impact factor: 8.694

10.  Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study.

Authors:  X Jiang; S R Srinivasan; L S Webber; W A Wattigney; G S Berenson
Journal:  Arch Intern Med       Date:  1995-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.